These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 18977262)
1. A clinical grade poly I:C-analogue (Ampligen) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro. Navabi H; Jasani B; Reece A; Clayton A; Tabi Z; Donninger C; Mason M; Adams M Vaccine; 2009 Jan; 27(1):107-15. PubMed ID: 18977262 [TBL] [Abstract][Full Text] [Related]
2. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer. Jasani B; Navabi H; Adams M Vaccine; 2009 May; 27(25-26):3401-4. PubMed ID: 19200817 [TBL] [Abstract][Full Text] [Related]
3. Dendritic cell maturation with poly(I:C)-based versus PGE2-based cytokine combinations results in differential functional characteristics relevant to clinical application. Möller I; Michel K; Frech N; Burger M; Pfeifer D; Frommolt P; Veelken H; Thomas-Kaskel AK J Immunother; 2008 Jun; 31(5):506-19. PubMed ID: 18463533 [TBL] [Abstract][Full Text] [Related]
4. Poly(I:C) used for human dendritic cell maturation preserves their ability to secondarily secrete bioactive IL-12. Rouas R; Lewalle P; El Ouriaghli F; Nowak B; Duvillier H; Martiat P Int Immunol; 2004 May; 16(5):767-73. PubMed ID: 15096480 [TBL] [Abstract][Full Text] [Related]
5. Not all polyriboinosinic-polyribocytidylic acids (Poly I:C) are equivalent for inducing maturation of dendritic cells: implication for alpha-type-1 polarized DCs. Avril T; de Tayrac M; Leberre C; Quillien V J Immunother; 2009 May; 32(4):353-62. PubMed ID: 19342970 [TBL] [Abstract][Full Text] [Related]
6. Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial. Navabi H; Croston D; Hobot J; Clayton A; Zitvogel L; Jasani B; Bailey-Wood R; Wilson K; Tabi Z; Mason MD; Adams M Blood Cells Mol Dis; 2005; 35(2):149-52. PubMed ID: 16061407 [TBL] [Abstract][Full Text] [Related]
7. Ampligen inhibits human herpesvirus-6 in vitro. Ablashi DV; Berneman ZN; Williams M; Strayer DR; Kramarsky B; Suhadolnik RJ; Reichenbach N; Hiltzges P; Komaroff AL In Vivo; 1994; 8(4):587-91. PubMed ID: 7893986 [TBL] [Abstract][Full Text] [Related]
8. CD40 engagement strongly induces CD25 expression on porcine dendritic cells and polarizes the T cell immune response toward Th1. Pilon C; Levast B; Meurens F; Le Vern Y; Kerboeuf D; Salmon H; Velge-Roussel F; Lebranchu Y; Baron C Mol Immunol; 2009 Jan; 46(3):437-47. PubMed ID: 19036453 [TBL] [Abstract][Full Text] [Related]
9. Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C). Echeverría I; Zabaleta A; Silva L; Díaz-Valdés N; Riezu-Boj JI; Lasarte JJ; Borrás-Cuesta F; Civeira MP; Prieto J; Sarobe P J Viral Hepat; 2008 Nov; 15(11):782-9. PubMed ID: 18637068 [TBL] [Abstract][Full Text] [Related]
10. Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]:poly [C(12)U] (Ampligen R). Adams M; Navabi H; Jasani B; Man S; Fiander A; Evans AS; Donninger C; Mason M Vaccine; 2003 Jan; 21(7-8):787-90. PubMed ID: 12531360 [TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor-3 as a target to enhance bioactivity of cancer immunotherapy. Nicodemus CF; Wang L; Lucas J; Varghese B; Berek JS Am J Obstet Gynecol; 2010 Jun; 202(6):608.e1-8. PubMed ID: 20080226 [TBL] [Abstract][Full Text] [Related]
12. TLR triggering on tolerogenic dendritic cells results in TLR2 up-regulation and a reduced proinflammatory immune program. Chamorro S; García-Vallejo JJ; Unger WW; Fernandes RJ; Bruijns SC; Laban S; Roep BO; 't Hart BA; van Kooyk Y J Immunol; 2009 Sep; 183(5):2984-94. PubMed ID: 19648269 [TBL] [Abstract][Full Text] [Related]
13. Differential roles of PI3-Kinase, MAPKs and NF-kappaB on the manipulation of dendritic cell T(h)1/T(h)2 cytokine/chemokine polarizing profile. Neves BM; Cruz MT; Francisco V; Garcia-Rodriguez C; Silvestre R; Cordeiro-da-Silva A; Dinis AM; Batista MT; Duarte CB; Lopes MC Mol Immunol; 2009 Aug; 46(13):2481-92. PubMed ID: 19520433 [TBL] [Abstract][Full Text] [Related]
14. [Effects of ovarian carcinoma cells on the maturation and function of human dendritic cells]. Li CD; Zhang WY; Yuan CL; Han LY Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):630-4. PubMed ID: 19595165 [TBL] [Abstract][Full Text] [Related]
15. An immunomodulatory protein, Ling Zhi-8, induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and MAPK pathways. Lin YL; Liang YC; Tseng YS; Huang HY; Chou SY; Hseu RS; Huang CT; Chiang BL J Leukoc Biol; 2009 Oct; 86(4):877-89. PubMed ID: 19498044 [TBL] [Abstract][Full Text] [Related]
16. IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. Bai H; Cheng J; Gao X; Joyee AG; Fan Y; Wang S; Jiao L; Yao Z; Yang X J Immunol; 2009 Nov; 183(9):5886-95. PubMed ID: 19812198 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of an alpha-C-galactosylceramide analogue that induces Th1-biased responses in human natural killer T cells. Lu X; Song L; Metelitsa LS; Bittman R Chembiochem; 2006 Nov; 7(11):1750-6. PubMed ID: 17009272 [TBL] [Abstract][Full Text] [Related]
18. Polysaccharide-protein complex from Lycium barbarum L. is a novel stimulus of dendritic cell immunogenicity. Chen Z; Lu J; Srinivasan N; Tan BK; Chan SH J Immunol; 2009 Mar; 182(6):3503-9. PubMed ID: 19265128 [TBL] [Abstract][Full Text] [Related]
19. Neonatal goats display a stronger TH1-type cytokine response to TLR ligands than adults. Tourais-Esteves I; Bernardet N; Lacroix-Lamandé S; Ferret-Bernard S; Laurent F Dev Comp Immunol; 2008; 32(10):1231-41. PubMed ID: 18514862 [TBL] [Abstract][Full Text] [Related]